article

European Pharmaceutical Review Issue 3 2020

In this issue is a discussion on the promise of virally vectored DNA and mRNA vaccines to combat COVID-19 as well as articles on how packaging could help to ensure patient adherence, regulatory issues for medicines and diagnostics during the pandemic and the benefits of digitalising the pharmaceutical supply chain. Also included are features on rapid microbiological methods and US biosimilar patent considerations. 

Included in this issue:

  • REGULATORY INSIGHT
    Life sciences M&A activity during the global pandemic
    Theo Godfrey and Russell Hoare, CMS
  • QA/QC & ANALYTICAL TECHNIQUES
    Raman imaging in pharmaceutical research – an overview
    Harald Fischer, Damon Strom, Miriam Boehmler, Eleni Kallis and Thomas Dieing, WITec
  • COVID-19
    Patents and approvals – medicines, vaccines and diagnostics for COVID-19 
    Paul England, Anja Lunze, Jan Phillip Rektorschek, Angela Knierim and Alison Dennis, Taylor Wessing
  • ENDOTOXINS
    The impact of supply chain risks and LAL reliance
    Kevin L Williams and Brendan Tindall, bioMérieux
  • FORMULATION, DEVELOPMENT & DELIVERY
    How implantable systems and microparticle depot injections are meeting the needs of long-acting drug delivery
    Kimberly Zubris and Jite Okoh, LLS Health
  • MANUFACTURING, PACKAGING & LOGISTICS
    The circuit of life: saving on manufacturing, waste and delivery-related supply chain inefficiencies
    Dr Dave Berry and Dr Alex Cole, CPI
  • BIOPROCESSING & BIOPRODUCTION
    Five patent issues that European biosimilar developers should consider before entering the US market
    Joshua Whitehill, Natasha Daughtrey and Grace Truong, Goodwin Procter LLP

The rest of this content is restricted - login or subscribe free to access

EPR Issue 5 front coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here